AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

Find US Patent Information with US Patent Number, Application Number and Patent Expiration Date of Lanthanum Carbonate on PharmaCompass.com

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

EU WC

EU WC

Listed Suppliers

Listed Suppliers

API REF. PRICE (USD / KG)
175
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

left grey arrow
right gray arrow
  • TABLET, CHEWABLE;ORAL - EQ 1GM BASE
  • TABLET, CHEWABLE;ORAL - EQ 500MG BASE
  • TABLET, CHEWABLE;ORAL - EQ 750MG BASE
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
7465465
Y
2024-08-26
21468
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
7381428
2024-08-26
U-890
21468
REDUCTION OF SERUM PHOSPHATE IN PATIENTS WITH END STAGE RENAL DISEASE
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
7465465
Y
2024-08-26
21468
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
9023397
Y
2030-12-01
204734
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
7465465
Y
2024-08-26
21468
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
7381428
2024-08-26
U-890
21468
REDUCTION OF SERUM PHOSPHATE IN PATIENTS WITH END STAGE RENAL DISEASE
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
7465465
Y
2024-08-26
21468
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
9023397
Y
2030-12-01
204734
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
7465465
Y
2024-08-26
204734
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content